Market Report, "Portugal Pharmaceuticals & Healthcare Report Q4 2013", Published
Portugal's economy continues to struggle in the face of austerity measures implemented as part of the IMF/ECB/EU's financial assistance package, rising unemployment and falling private consumption. The healthcare and pharmaceuticals market continues to suffer as a result. Price cuts, reduced investment in healthcare infrastructure and enforced prescriptions by active ingredients are just some of the measures affecting the sector, making opportunities for growth and investment few and far between. Only generic drugmakers are benefiting - but more in volume terms...
View full press release